No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MDWD240816P17500
- 1.10
- +0.10+10.00%
15min DelayClose Jul 19 15:59 ET
1.10High1.10Low
1.10Open1.00Pre Close2 Volume18 Open Interest17.50Strike Price220.00Turnover84.80%IV11.83%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry1.10Extrinsic Value100Contract SizeAmericanOptions Type-0.3453Delta0.0882Gamma16.91Leverage Ratio-0.0293Theta-0.0048Rho-5.84Eff Leverage0.0182Vega
Intraday
- 5D
- Daily
News
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating
Maxim Group analyst Michael Okunewitch maintains $MediWound(MDWD.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 29.0% and a total average return of -15.8% over
MediWound Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
MediWound Price Target Maintained With a $28.00/Share by HC Wainwright & Co.
HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MediWound (NASDAQ:MDWD) with a Buy and maintains $28 price target.
MediWound Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/16/2024 34.94% HC Wainwright & Co. $28 → $28 Reiterates Buy → Buy 05/30/2024 34.94% HC Wainwright & Co.
MediWound Accelerates DFU Treatment With EIC Funds
Express News | MediWound Selected For €16.25M Funding From The European Innovation Council Accelerator Program
Comments
$MediWound(MDWD.US$ any thoughts??
1
$MediWound(MDWD.US$ Watching / Looking for confirmation of rumor that $Solventum(SOLV.US$ is offering a $34 PS takeover bid?
1
6
$MediWound(MDWD.US$ MediWound Says FDA Accepted For Review The Supplement To The NexoBrid BLA To Include Pediatric Patients With Severe Thermal Burns![]()
Read more